OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Merger with pharmacovigilance service provider helps company expands its end-to-end solutions in the region.
PharmaLex, a healthcare and life sciences consulting and outsourcing service provider, is merging with Cpharm, a company that offers pharmacovigilance and medical services in Australia and New Zealand.
The merger plan consists of growing PharmaLex’s footprint in the aforementioned countriesthrough Cpharm’s expert capabilities in drug and device vigilance in the region, while offering complementary services and expanding the service portfolio of both companies. Cpharm has been providing a range of pharmacovigilance, safety and risk management, medical information, material review, and patient program services to support clients that range from start-ups to top-10 multinational pharma companies.
“The merger with Cpharm will benefit both our businesses as well as our experts and our clients, allowing us to offer end-to-end solutions in the Australian market, while at the same time expanding our long and proven working relationship with Cpharm,” says Grant Bennett, PharmaLex managing director, Australia. “The agreement will enable PharmaLex to increase our coverage of pharmacovigilance and medical services in Australia and build interactions with the local client base to drive further growth for both organizations.”